Antiestrogen therapy in pancreatic carcinoma: a preliminary report.
Ten patients with unresected pancreatic carcinoma, treated with Nolvadex 10 mg 3 times a day were compared to a historic untreated control group. The median survival was 7 months in the treated group compared to 3 months in the untreated. In the control group all patients died within the first 9 months, in the treated group 40% of the patients were still alive after 14 months.
D000368:Aged; D002277:Carcinoma / Q000401:mortality / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000628:therapy*; D010865:Pilot Projects; D013629:Tamoxifen / Q000627:therapeutic use*
D013629:Tamoxifen